Ventyx Biosciences Inc (VTYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 42,552 | 38,571 | 31,420 | 20,398 | 22,747 |
| Operating Income | -42,552 | -38,571 | -31,420 | -20,398 | -22,747 |
| Other Income | 3,621 | 3,357 | 958 | 380 | 15 |
| Pre-tax Income | -38,931 | -35,214 | -30,462 | -20,018 | -22,732 |
| Net Income Continuous | -38,931 | -35,214 | -30,462 | -20,018 | -22,732 |
| Net Income | $-38,931 | $-35,214 | $-30,462 | $-20,018 | $-22,732 |
| EPS Basic Total Ops | -0.68 | -0.64 | -0.59 | -0.39 | -0.45 |
| EPS Basic Continuous Ops | -0.68 | -0.63 | -0.59 | -0.39 | -0.45 |
| EPS Diluted Total Ops | -0.68 | -0.64 | -0.59 | -0.39 | -0.45 |
| EPS Diluted Continuous Ops | -0.68 | -0.63 | -0.59 | -0.39 | -0.45 |
| EBITDA(a) | $-42,418 | $-38,421 | $-31,293 | $-20,295 | $-22,657 |